Nuclear Radiology: Page 54

Eckert posts sales, profit gains in Q1

By AuntMinnieEurope.com staff writers

Sales increases in all key product groups helped isotope technology developer Eckert & Ziegler to a 16% growth in sales for its first quarter.

May 5, 2014

Start-up firm Blue Earth Diagnostics develops prostate PET agent

By Wayne Forrest

Researchers from GE Healthcare have set out on their own with Blue Earth Diagnostics, a start-up with plans to commercialize a PET radiopharmaceutical they hope will prove more useful than FDG for detecting and assessing recurrent prostate cancer.

May 4, 2014

Eckert & Ziegler posts 2013 sales decreases

By AuntMinnieEurope.com staff writers

Isotope technology firm Eckert & Ziegler has posted a decrease in sales for its fiscal year 2013, although the company remains optimistic for its 2014 outlook.

March 27, 2014

Navidea's PET agent featured at German nuclear medicine congress

By AuntMinnieEurope.com staff writers

Navidea Biopharmaceuticals has announced its PET imaging agent NAV4694 is the subject of several presentations at this week's German Society of Nuclear Medicine annual congress.

March 26, 2014

IBA sees drop in fiscal 2013 revenues

By AuntMinnieEurope.com staff writers

Ion Beam Applications (IBA) experienced a drop in revenue from sales and services for fiscal year 2013.

March 25, 2014

CT perfusion useful for evaluating small esophageal tumors

By Rabia Mughal

CT perfusion can be used to evaluate esophageal cancers with small tumor diameters that are not amenable to assessment with PET/CT, according to a new study by Turkish researchers presented at ECR 2014 earlier this month.

March 20, 2014

IBA divests PharmaLogic PET Services

By AuntMinnieEurope.com staff writers

Ion Beam Applications (IBA) has sold the assets of its PharmaLogic PET Services of Montreal subsidiary to a private equity firm.

March 16, 2014

Global nuclear medicine market poised for growth

By AuntMinnieEurope.com staff writers

The global nuclear medicine market will reach $24 billion by 2030 (18 billion euros), with an annual average increase of 11%, according to a new market research report by MEDraysintell.

March 13, 2014

MILabs wins Dutch contract

By AuntMinnieEurope.com staff writers

MILabs has won an installation of its MILabs U-SPECT+/CT system at a Dutch cancer institute.

March 10, 2014

Study finds PET/CT can help diagnose CUP syndrome

By Erik L. Ridley

VIENNA - FDG-PET/CT can identify a possible primary tumor in patients with carcinoma with unknown primary tumor (CUP) syndrome at a rate comparable to that found in autopsy studies, German researchers reported on Monday at ECR 2014.

March 9, 2014

Controversy breaks out over how to study cell death in cancer

By Philip Ward

VIENNA - When Dr. Uwe Haberkorn drew breath after his ECR presentation during a New Horizons session on imaging the hallmarks of cancer, he probably didn't anticipate the lively debate that was to follow.

March 8, 2014

Hybrid imaging gathers momentum in cardiac indications

By Becky McCall

VIENNA - Hybrid imaging is gaining acceptance as opportunities using combinations of modalities emerge and promise to optimize cardiac imaging, according to expert speakers in today's session called "Hybrid cardiovascular imaging: Where should we go?" at ECR 2014.

March 5, 2014

Previous Page

Page 54 of 90

Next Page